<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-biomedicines-08-00060">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kim</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>C.W.</given-names>
   </name>
   <name>
    <surname>Kovacic</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Shah</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Klasa</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Savage</surname>
    <given-names>K.J.</given-names>
   </name>
  </person-group>
  <article-title>Long-term survival in patients with metastatic melanoma treated with DTIC or temozolomide</article-title>
  <source>Oncologist</source>
  <year>2010</year>
  <volume>15</volume>
  <fpage>765</fpage>
  <lpage>771</lpage>
  <pub-id pub-id-type="doi">10.1634/theoncologist.2009-0237</pub-id>
  <pub-id pub-id-type="pmid">20538743</pub-id>
 </element-citation>
</ref>
